SGLT2 Inhibitor Utilization Re-perfusion Therapy

Clinical trial NCT06858436 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06858436
Sponsor: Taichung Veterans General Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Ischemic Stroke From Large Vessel Occlusion

Start date: 2026-04-13
Primary completion: 2027-10-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.